Patient Square Capital LP
CIK: 0001819257Latest portfolio: $467.1M · Q4 2025
Holdings
28
Total Value
$467.1M
New Positions
9
Closed Positions
5
Top Holdings
View All 28 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ROIVROIVANT SCIENCES LTD | 8,166,047 | $177.2M | 37.93% | -4,313,953 | |
| 2 | IM8NINSMED INC | 267,000 | $46.5M | 9.95% | -59,400 | |
| 3 | MIRMMIRUM PHARMACEUTICALS INC | 298,682 | $23.6M | 5.05% | +194K | |
| 4 | ARGXARGENX SE | 26,000 | $21.9M | 4.68% | +11K | |
| 5 | ONCBEONE MEDICINES LTD | 69,312 | $21.1M | 4.51% | NEW | |
| 6 | ABVXABIVAX SA | 130,000 | $17.5M | 3.75% | -21,833 | |
| 7 | PHVSPHARVARIS N V | 542,696 | $15.1M | 3.22% | +197K | |
| 8 | EYPTEYEPOINT INC | 780,000 | $14.3M | 3.05% | -231,839 | |
| 9 | TERNTERNS PHARMACEUTICALS INC | 320,000 | $12.9M | 2.77% | NEW | |
| 10 | CELCCELCUITY INC | 120,000 | $12.0M | 2.56% | +20K | |
| 11 | COGTCOGENT BIOSCIENCES INC | 317,372 | $11.3M | 2.41% | NEW | |
| 12 | KYMRKYMERA THERAPEUTICS INC | 139,000 | $10.8M | 2.32% | +46K | |
| 13 | LQDALIQUIDIA CORPORATION | 227,000 | $7.8M | 1.68% | -173,000 | |
| 14 | DBVTDBV TECHNOLOGIES S A | 359,050 | $6.9M | 1.47% | NEW | |
| 15 | ALLOALLOGENE THERAPEUTICS INC | 4,963,756 | $6.8M | 1.46% | +2.0M | |
| 16 | DNTHDIANTHUS THERAPEUTICS INC | 150,000 | $6.2M | 1.32% | +25K | |
| 17 | XENEXENON PHARMACEUTICALS INC | 136,500 | $6.1M | 1.31% | NEW | |
| 18 | ARQTARCUTIS BIOTHERAPEUTICS INC | 210,000 | $6.1M | 1.31% | NEW | |
| 19 | OCULOCULAR THERAPEUTIX INC | 490,000 | $5.9M | 1.27% | -225,000 | |
| 20 | IRONDISC MEDICINE INC | 74,000 | $5.9M | 1.26% | — | |
| 21 | AVTXAVALO THERAPEUTICS INC | 311,966 | $5.7M | 1.21% | +212K | |
| 22 | SYRESPYRE THERAPEUTICS INC | 150,000 | $4.9M | 1.05% | NEW | |
| 23 | ELVNENLIVEN THERAPEUTICS INC | 308,141 | $4.7M | 1.02% | +57K | |
| 24 | ASMBASSEMBLY BIOSCIENCES INC | 127,000 | $4.3M | 0.92% | -8,182 | |
| 25 | AMLXAMYLYX PHARMACEUTICALS INC | 350,000 | $4.2M | 0.91% | +34K |
Quarterly Changes
New Positions
Sector Breakdown
Healthcare0.0% ($1.7720323592218643e+109T)
Unknown0.0% ($46.5M)
Filing History
Fund Information
Patient Square Capital LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $467.1M across 28 holdings. The largest position is ROIVANT SCIENCES LTD (ROIV), representing 37.9% of the portfolio. Compared to the previous quarter, the fund opened 9 new positions and closed 5 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.